Overview
Technology That Permits Focal Dose of Antibiotics to be Delivered to Lower Limb(s) of Diabetic Patients
Status:
Completed
Completed
Trial end date:
2015-03-01
2015-03-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The use of the Percutaneous Isolated Limb Procedure (PILP) which enables the use of existing antibiotic therapies in a more targeted and concentrated fashion in patients with diabetes who have a significant lower limb infection and it is deemed that IV antibiotics are needed in order to salvage the limb or life.Phase:
Phase 2Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Osprey Medical, IncTreatments:
Anti-Bacterial Agents
Antibiotics, Antitubercular
Clavulanic Acid
Clavulanic Acids
Ticarcillin
Ticarcillin-clavulanic acid
Criteria
Inclusion Criteria:- M or F subjects 18 - 90 years old
- Subject has pre-existing diabetes diagnosis
- Subject has significant infection below the ankle of soft tissue and may include bone,
and IV antibiotics are needed in order to salve limb or life
- Consequence of infected wound would require Std of Care share debridement
- Subject willing and able to provide written informed consent
- Subject willing and able to comply with requirements of study protocol including
pre-defined follow-up evaluations
- PROCEDURAL INCLUSION CRITERIA: successful cannulation of the femoral artery and vein
and placement of the venous support device
Exclusion Criteria:
- Allergy to contrast media
- Known bleeding disorder including thrombocytopenia
- Recent AMI or elevated Troponin levels within last 30 days
- Penicillin sensitivity; Timentin sensitivity
- Female subjects known to be or suspected to be pregnant or lactating
- Subject unable to comply with instructions; especially to remain supine for duration
of recirculation procedure
- Subjects who have participated in any other clinical trial or taken investigational
drug within 30 days of study enrollment
- The PI determines the subject is not an appropriate subject for the study
- PROCEDURAL EXCLUSION CRITERIA: Subjects anatomy interferes with or is expected to
prohibit successful cannulation of the femoral vessels or placement of the venous
support device
- Known severe proximal femoral artery vascular disease precluding placement of
perfusion catheters